Turner Syndrome Mosaicism 46,Xx/45,X with Graves' Disease: A Case Report
DOI:
https://doi.org/10.66266/inajemd.v2i2.67Keywords:
Turner's syndrome, mosaicism, Graves' disease, HyperthyroidismAbstract
Background: Turner syndrome (TS) is a condition in females missing the second sex chromosome (45,X) or parts thereof. It is a rare genetic condition with a wide range of clinical stigmata, such as short stature, delayed puberty and infertility, congenital malformations, and endocrine disorders. TS with chromosomal mosaicism (TSM) is a less severe and less frequent form of TS, who has less pronounced signs and symptoms than the classic TS.
Case Illustration: A 21-year-old woman with TSM and Graves' disease (GD) is reported. She presented with fatigue, sweating, palpitation, tremor, and the absence of menstruation or breast development. Further investigation reveals diffuse enlargement of thyroid gland and hyperthyroidism symptoms. Laboratory testing shows elevated fT4, low TSH, and elevated TSH receptor antibody levels. Previous chromosomal analysis showed a mosaicism: 46,XX,dup(X) (q28q21.2)[36]/45,X[4]. She is then treated with thiamazole and oral beta-blocker.
Discussion: Thyroid abnormalities is common in TS, especially in adult females. This including Hashimoto's thyroiditis and GD. But TS presenting with hyperthyroidism is rare, with most of the cases were reported happens in adult females. Mosaicism in TS resulted in less severe signs and symptoms than the classic TS. Therefore, based on the variabilities, it is often undetected.
Conclusion: We reported a rare case of TSM with GD. We observed that mosaicism in this TS patient resulted in less severe GD symptoms, and the response to conventional treatment with thiamazole and oral beta-blocker was satisfactory.
Downloads
References
1. Gravholt CH, Andersen NH, Conway GS, Dekkers
OM, Geffner ME, Klein KO, et al. Clinical practice
guidelines for the care of girls and women
with Turner syndrome: proceedings from the
2016 Cincinnati International Turner Syndrome
Meeting. Eur J Endocrinol 2017;177(3):G1-G70.
2. Turner HH. A syndrome of infantilism, congenital
webbed neck, and cubitus valgus. Endocrinology
1938;23(5):566-74.
3. Ford CE, Jones KW, Polani PE, De Almeida JC,
Briggs JH. A sex-chromosome anomaly in a
case of gonadal dysgenesis (Turner's syndrome).
Lancet 1959;1:711-3.
4. Gravholt CH, Viuff M, Just J, Sandahl K, Brun S, van
der Velden J, et al. The changing face of Turner
syndrome. Endocr Rev 2023;44(1):33-69.
5. Iourov IY, Vorsanova SG, Yurov YB, Kutsev
SI. Ontogenetic and pathogenetic views on
somatic chromosomal mosaicism. Genes (Basel)
2019;10(5):379.
6. Naessen S, Eliasson M, Berntrop K, Kitlinski
M, Trimpou P, et al. Autoimmune disease in
Turner syndrome in Sweden: an up to 25 years'
controlled follow-up study. J Clin Endocrinol
Metab 2024;109(2):e602-12.
7. Zinn AR, Tonk VS, Chen Z, Flejter WL, Gardner HA,
Guerra R, et al. Evidence for a Turner syndrome
locus or loci at Xp11.2-p22.1. Am J Hum Genet
1998;63:1757-66.
8. Gawlik AM, Berdej-Szczot E, Blat D, Klekotka R,
Gawlik T, Blaszczyk E, et al. Immunological profile
and predisposition to autoimmunity in girls with
Turner syndrome. Front Endocrinol 2018;9:307.
9. Bondi CA. Turner Syndrome Study Group. Care
of girls and women with Turner syndrome: a
guideline of the Turner Syndrome Study Group.
J Clin Endocrinol Metab 2007;92:10-25.
10. Mohamed SOO, Elkhidir IHE, Abuzied AIH,
Noureddin AAMH, Ibrahim GAA, Mahmoud
AAA. Prevalence of autoimmune thyroid disease
among the Turner syndrome patients: metaanalysis
of cross sectional studies. BMC Res Notes
2018;11:842.
11. Gravholt CH. Aspects of the treatment of
Turner syndrome. Expert Opin Pharmacother
2001;2(10):1633-47.
12. Wallis GA, Starman BJ, Zinn AB, Byers PH. Variable
expression of osteogenesis imperfecta in a
nuclear family is explained by somatic mosaicism
for a lethal point mutation in the alpha 1(I) gene
(COL1A1) of type I collagen in a parent. Am J Hum
Genet 1990;46(6):1034-40.
13. Tuke MA, Ruth KS, Wood AR, Beaumont RN,
Tyrrell J, Jones SE, et al. Mosaic Turner syndrome
shows reduced penetrance in adult population
study. Genet Med 2019;21(4):877-86.
14. El-Mansoury M, Barrenas M-L, Bryman I, Hanson
C, Larsson C, Wilhelmsen L, et al. Chromosomal
mosaicism mitigates stigmata and cardiovascular
risk factors in Turner syndrome. Clin Endocrinol
(Oxf) 2007;66(5):744-51.
15. Williams ED, Engel E, Forbes AP. Thyroiditis and
gonadal dysgenesis. N Eng J Med 1964;270:805-
10.
16. Livadas S, Xekouki P, Fouka F, Kanaka-Gantenbein
C, Kaloumenou I, Mavrou A, et al. Prevalence of
thyroid dysfunction in Turner's syndrome: a longterm
follow-up study and brief literature review.
Thyroid 2005;15(9):1061-6.
17. Wasniewska M, Corrias A, Messina MF, Crisafulli
G, Salzano G, Valenzise M, et al. Graves' disease
prevalence in a young population with Turner
syndrome. J Endocrinol Invest 2010;33:69-70.
18. Casto C, Pepe G, Li Pomi A, Corica D, Aversa
T, Wasniewska M. Hashimoto's thyroiditis and
Graves' disease in genetic syndromes in pediatric
age. Genes 2021;12:222.
19. Ludgate M, Emerson CH. Metamorphic thyroid
autoimmunity. Thyroid 2008;10:1035-7.
20. Aversa T, Lombardo F, Corrias A Salerno M, De
Luca F, Wasniewska M. In young patients with
Turner or Down syndrome, Graves' disease
presentation is often preceded by Hashimoto's
thyroiditis. Thyroid 2014;24(4):744-7.
21. Valenzise M, Aversa T, Corrias A, Mazzanti
L, Cappa M, Ubertini G, et al. Epidemiology
presentation and long-term evaluation of Graves'
disease in children, adolescents and young
adults with Turner syndrome. Horm Res Pediatr
2014;81:245-50.
22. Guseinova RM, Prosvirnina AA, Korchagina MO,
Trukhin AA, Sheremeta MS. Thyrotoxicosis in a
patient with Turner syndrome: radioactive iodine
therapy. Probl Endokrinol 2022;68(6):49-58.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD) the right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
© Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD). Published by the Indonesian Society of Endocrinology (PERKENI).
